Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PD-L1 Inhibitor Screening ELISA Kit

ELISA, ScA Reactivity: Human Colorimetric
Catalog No. ABIN2762507

Quick Overview for PD-L1 Inhibitor Screening ELISA Kit (ABIN2762507)

Target

See all PD-L1 Kits
PD-L1 (CD274 (PD-L1))

Reactivity

  • 10
  • 6
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Detection Method

Colorimetric

Application

ELISA, Screening Assay (ScA)
  • Method Type

    Sandwich ELISA

    Detection Range

    0.0125 μg/mL - 0.2 μg/mL

    Minimum Detection Limit

    0.0125 μg/mL

    Purpose

    PD-L1 Inhibitor Screening ELISA Kit: This kit is developed for screening for inhibitors of human PD-1 binding to human PD-L1.

    Components

    High-bind Plate
    Human PD-L1
    Anti-PD-1 Neutralizing Antibody
    Human PD-1-Biotin
    Streptavidine-HRP
    Coating Buffer
    10x Washing Buffer
    Blockung Buffer
    Substrate Solution
    Stop Solution
  • Application Notes

    The antibody pair is useful for screening for inhibitors of human PD-1 binding to human PD-L1.

    Comment

    METHOD VERIFICATION
    PD-1 [BIOTINYLATED]:PD-L1 BINDING IN THE ABSENCE OF INHIBITORS:
    Immobilized human PD-L1 protein at 2 μg/mL (100 μL/well) can bind human PD-1-Biotin with a linear range of 0.01875-0.3 μg/mL when detected by Streptavidin-HRP. Background was subtracted from data points before curve fitting.

    INHIBITION OF PD-1 [BIOTINYLATED] : PD-L1 BINDING BY ANTI-PD-1 NEUTRALIZING ANTIBODY
    Serial dilutions of anti-PD-1 neutralizing antibody (1:2 serial dilutions, from 10 μg/mL to 0.078 μg/mL) was added into PD-L1 : PD-1-Biotin binding reactions. The assay was performed according to the above described protocol. Background was subtracted from data points prior to log transformation and curve fitting.
    Preparation of Standard Serial Dilutions
    1) Pipette 480 μL Dilution Buffer into tube Std-1 and 150 μL Dilution Buffer into the remaining tubes (tube Std.-2 to tube Std.-8).
    2) Add 20 μL anti-PD-1 neutralizing antibody stock solution (250 μg/mL) to tube Std.-1 to make the final concentration 10 μg/mL. Mix well.
    3) To make a 1:2 serial dilutions, pipette 150 μL solution to the next tube as illustrated in Fig.3.
    IMPORTANT: Mix thoroughly at each step during the dilution process.

    Protocol

    This assay employs a simple colorimetric ELISA platform, which measures the binding between immobilized human PD-L1 and in-house developed biotinylated PD-1 protein. This product is uniquely suitable for rapid high-throughput screening of putative PD-1 and PD-L1 inhibitors. Briefly, we provide you with a human PD-1-Biotin protein, a human PD-L1 protein, an anti-PD-1 neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent. Your experiment will include 4 simple steps:
    • Coat the plate with human PD-L1.
    • Add your molecule of interest to the tests.
    • Add human PD-1-Biotin to bind the coated human PD-L1.
    • Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.
    Finally, the ability of your compound to inhibit PD-1 : PD-L1 binding will be determined by comparing OD readings among different experimental groups

    Restrictions

    For Research Use only
  • Storage

    4 °C

    Storage Comment

    The unopened kit is stable for 12 months from the date of manufacture if stored at 2°C to 8°C.
  • Target

    PD-L1 (CD274 (PD-L1))

    Alternative Name

    PD-1,PD-L1

    Background

    Immune checkpoint pathway is a focal point of today's cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body's immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.
You are here:
Chat with us!